L

LIXT

Lixte Biotechnology Hldgs Inc

4.22

-0.23-5.17%
Opening14:24 09/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE4.230/4.450
TODAY RANGE4.021-4.400
VOL45.52K
MARKET CAP19.25M
52 WEEK RANGE0.6400-5.14
AVG VOL (3M)2.09M
% TURNOVER1.00%
TURNOVER--
P/E (TTM)-3.2835
% RANGE8.52%
EPS(TTM)-1.2852
P/E(FORWARD)--
P/B17.86
BVPS0.2363
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP17.16M
SHARES OUTSTANDING4.56M
NEXT EARNINGS11/10-11/14
FREE FLOAT4.07M
LOT SIZE1
EX-DATE06/05/2023
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

L

Lixte Biotechnology Hldgs Inc

LIXT

-5.17%
4.22

R

Regeneron Pharmaceuticals

REGN

-0.67%
576.79

E

Entero Therapeutics

ENTO

+20.00%
2.73

B

BIONTECH

BNTX

-0.09%
99.92

U

United Therapeutics Corp.

UTHR

+34.77%
410.73

S

Siga Technologie

SIGA

+1.79%
8.54

V

Vertex Pharmaceuticals Inc

VRTX

+2.23%
399.74

M

Moderna

MRNA

-0.79%
23.90

C

Charles Riv Labs Intl Inc

CRL

-1.65%
160.61

M

Medpace Holdings

MEDP

-0.79%
471.77

T

Talphera Inc

TLPH

-3.38%
0.5227

I

ICON PLC

ICLR

-0.29%
177.43

C

China Biologic

CBPO

0.00%
119.99

I

Iqvia Hldgs Inc

IQV

-3.44%
184.25

M

MOLECULAR PARTNERS AG

MOLN

+1.75%
3.82

A

Arcturus Therape

ARCT

-1.00%
16.84

P

PRA Health

PRAH

0.00%
165.21

G

Gilead Sciences Inc

GILD

-0.37%
112.55

A

Aptevo Therapeutics Inc

APVO

-3.05%
1.59

I

Incyte Corp

INCY

+2.42%
86.66

B

Biospecifics

BSTC

0.00%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.